193 related articles for article (PubMed ID: 21110803)
1. Targeting the Nogo receptor complex in diseases of the central nervous system.
McDonald CL; Bandtlow C; Reindl M
Curr Med Chem; 2011; 18(2):234-44. PubMed ID: 21110803
[TBL] [Abstract][Full Text] [Related]
2. Ganglioside mediate the interaction between Nogo receptor 1 and LINGO-1.
Saha N; Kolev MV; Semavina M; Himanen J; Nikolov DB
Biochem Biophys Res Commun; 2011 Sep; 413(1):92-7. PubMed ID: 21872576
[TBL] [Abstract][Full Text] [Related]
3. Structural features of the Nogo receptor signaling complexes at the neuron/myelin interface.
Saha N; Kolev M; Nikolov DB
Neurosci Res; 2014 Oct; 87():1-7. PubMed ID: 24956133
[TBL] [Abstract][Full Text] [Related]
4. TAJ/TROY, an orphan TNF receptor family member, binds Nogo-66 receptor 1 and regulates axonal regeneration.
Shao Z; Browning JL; Lee X; Scott ML; Shulga-Morskaya S; Allaire N; Thill G; Levesque M; Sah D; McCoy JM; Murray B; Jung V; Pepinsky RB; Mi S
Neuron; 2005 Feb; 45(3):353-9. PubMed ID: 15694322
[TBL] [Abstract][Full Text] [Related]
5. LINGO-1 is a component of the Nogo-66 receptor/p75 signaling complex.
Mi S; Lee X; Shao Z; Thill G; Ji B; Relton J; Levesque M; Allaire N; Perrin S; Sands B; Crowell T; Cate RL; McCoy JM; Pepinsky RB
Nat Neurosci; 2004 Mar; 7(3):221-8. PubMed ID: 14966521
[TBL] [Abstract][Full Text] [Related]
6. Limiting multiple sclerosis related axonopathy by blocking Nogo receptor and CRMP-2 phosphorylation.
Petratos S; Ozturk E; Azari MF; Kenny R; Lee JY; Magee KA; Harvey AR; McDonald C; Taghian K; Moussa L; Mun Aui P; Siatskas C; Litwak S; Fehlings MG; Strittmatter SM; Bernard CC
Brain; 2012 Jun; 135(Pt 6):1794-818. PubMed ID: 22544872
[TBL] [Abstract][Full Text] [Related]
7. Characterization of myelin ligand complexes with neuronal Nogo-66 receptor family members.
Laurén J; Hu F; Chin J; Liao J; Airaksinen MS; Strittmatter SM
J Biol Chem; 2007 Feb; 282(8):5715-25. PubMed ID: 17189258
[TBL] [Abstract][Full Text] [Related]
8. A TNF receptor family member, TROY, is a coreceptor with Nogo receptor in mediating the inhibitory activity of myelin inhibitors.
Park JB; Yiu G; Kaneko S; Wang J; Chang J; He XL; Garcia KC; He Z
Neuron; 2005 Feb; 45(3):345-51. PubMed ID: 15694321
[TBL] [Abstract][Full Text] [Related]
9. Molecular basis of the interactions of the Nogo-66 receptor and its homolog NgR2 with myelin-associated glycoprotein: development of NgROMNI-Fc, a novel antagonist of CNS myelin inhibition.
Robak LA; Venkatesh K; Lee H; Raiker SJ; Duan Y; Lee-Osbourne J; Hofer T; Mage RG; Rader C; Giger RJ
J Neurosci; 2009 May; 29(18):5768-83. PubMed ID: 19420245
[TBL] [Abstract][Full Text] [Related]
10. LINGO-1 protein interacts with the p75 neurotrophin receptor in intracellular membrane compartments.
Meabon JS; De Laat R; Ieguchi K; Wiley JC; Hudson MP; Bothwell M
J Biol Chem; 2015 Apr; 290(15):9511-20. PubMed ID: 25666623
[TBL] [Abstract][Full Text] [Related]
11. Altered expression of myelin-associated inhibitors and their receptors after traumatic brain injury in the mouse.
Israelsson C; Flygt J; Åstrand E; Kiwanuka O; Bengtsson H; Marklund N
Restor Neurol Neurosci; 2014; 32(5):717-31. PubMed ID: 25079982
[TBL] [Abstract][Full Text] [Related]
12. Molecular dissection of the myelin-associated glycoprotein receptor complex reveals cell type-specific mechanisms for neurite outgrowth inhibition.
Venkatesh K; Chivatakarn O; Sheu SS; Giger RJ
J Cell Biol; 2007 May; 177(3):393-9. PubMed ID: 17470639
[TBL] [Abstract][Full Text] [Related]
13. Expression of the Nogo-A system in cortical lesions of pediatric patients with tuberous sclerosis complex and focal cortical dysplasia type IIb.
Yu SX; Li S; Shu HF; Zhang CQ; Liu SY; Yang H
J Neuropathol Exp Neurol; 2012 Jul; 71(7):665-77. PubMed ID: 22710967
[TBL] [Abstract][Full Text] [Related]
14. Myocilin is involved in NgR1/Lingo-1-mediated oligodendrocyte differentiation and myelination of the optic nerve.
Kwon HS; Nakaya N; Abu-Asab M; Kim HS; Tomarev SI
J Neurosci; 2014 Apr; 34(16):5539-51. PubMed ID: 24741044
[TBL] [Abstract][Full Text] [Related]
15. P75 interacts with the Nogo receptor as a co-receptor for Nogo, MAG and OMgp.
Wang KC; Kim JA; Sivasankaran R; Segal R; He Z
Nature; 2002 Nov; 420(6911):74-8. PubMed ID: 12422217
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of CNS myelin inhibition: evidence for distinct and neuronal cell type specific receptor systems.
Giger RJ; Venkatesh K; Chivatakarn O; Raiker SJ; Robak L; Hofer T; Lee H; Rader C
Restor Neurol Neurosci; 2008; 26(2-3):97-115. PubMed ID: 18820405
[TBL] [Abstract][Full Text] [Related]
17. Targeting the Nogo-A signalling pathway to promote recovery following acute CNS injury.
Walmsley AR; Mir AK
Curr Pharm Des; 2007; 13(24):2470-84. PubMed ID: 17692015
[TBL] [Abstract][Full Text] [Related]
18. Nogo receptor 3, a paralog of Nogo-66 receptor 1 (NgR1), may function as a NgR1 co-receptor for Nogo-66.
Zhang L; Kuang X; Zhang J
J Genet Genomics; 2011 Nov; 38(11):515-23. PubMed ID: 22133682
[TBL] [Abstract][Full Text] [Related]
19. The Nogo-66 receptor NgR1 is required only for the acute growth cone-collapsing but not the chronic growth-inhibitory actions of myelin inhibitors.
Chivatakarn O; Kaneko S; He Z; Tessier-Lavigne M; Giger RJ
J Neurosci; 2007 Jul; 27(27):7117-24. PubMed ID: 17611264
[TBL] [Abstract][Full Text] [Related]
20. Nogo receptor is involved in the adhesion of dendritic cells to myelin.
McDonald CL; Steinbach K; Kern F; Schweigreiter R; Martin R; Bandtlow CE; Reindl M
J Neuroinflammation; 2011 Sep; 8():113. PubMed ID: 21906273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
